Search Within

Martee L Hensley

Formats
  1. Journal Article (174)
  2. Meeting Abstract (106)
  3. Book Section (7)
  4. Correspondence (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (290)
  2. GDMT, Medicine (290)
  3. Gynecologic Medicine Service (290)
  4. Gynecology Disease Management Team (290)
  5. Solid Tumor Oncology Division (290)
  6. Surgery (129)

More Groups

People
  1. Carol Aghajanian (94)
  2. Paul Sabbatini (81)
  3. Robert Soslow (63)
  4. David Spriggs (55)
  5. Mario Leitao (53)
  6. Richard Barakat (53)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Gynecologic Oncology (73)
  3. International Journal of Gynecological Cancer (22)
  4. Modern Pathology (18)
  5. Clinical Cancer Research (15)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (81)
  3. Lippincott Williams & Wilkins (33)
  4. Nature Research (18)
  5. American Association for Cancer Research (17)
  6. Nature Publishing Group (13)

More Publishers

Results (290)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • PGR gene fusions identify a molecular subset of uterine epithelioid leiomyosarcoma with rhabdoid features
    Journal Article

    Chiang, S.; Samore, W.; Zhang, L.; Sung, Y. S.; Turashvili, G.; Murali, R.; Soslow, R. A.; Hensley, M. L.; Swanson, D.; Dickson, B. C.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • Reply to F. Tomao et al
    Correspondence

    Hensley, M. L.; Enserro, D.; Miller, D. S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study
    Meeting Abstract

    Hensley, M. L.; Enserro, D.; Hatcher, H.; Ottevanger, P. B.; Krarup-Hansen, A.; Blay, J. Y.; Fisher, C.; Moxley, K. M.; Lele, S. B.; Lea, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Hensley, M. L.; Enserro, D.; Hatcher, H.; Ottevanger, P. B.; Krarup-Hansen, A.; Blay, J. Y.; Fisher, C.; Moxley, K. M.; Lele, S. B.; Lea, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
    Journal Article

    Jones, R. L.; Demetri, G. D.; Schuetze, S. M.; Milhem, M.; Elias, A.; Van Tine, B. A.; Hamm, J.; McCarthy, S.; Wang, G.; Parekh, T.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save